Ftse Mib
36.516,84
-0,55%
DAX
21.416,55
-0,44%
S&P 500
6.037,88
0,72%
NASDAQ
19.654,02
1,35%
Bitcoin
97.808,23
-0,05%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NYSE Becton Dickinson and Company (BDX) Becton Dickinson and Company (BDX) Notizie

Becton Dickinson and Company

BDX
242,42
0,00 (0,00%)
05 Feb 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NYSE
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
31/1/202522:06EDGAR2Form 8-K - Current report
31/1/202501:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/1/202522:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/1/202522:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/1/202522:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/1/202522:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/1/202522:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/1/202521:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/1/202521:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/1/202521:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/1/202522:15PRNUSBD Board Declares Dividend, Authorizes 10 Million Additional..
23/1/202513:15PRNUSBD and Biosero Collaborate to Enable Robotic Integration..
23/1/202512:45BWBD and Biosero Collaborate to Enable Robotic Integration..
22/1/202515:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/1/202515:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/1/202512:50PRNUSCarilion Clinic First in Virginia to Offer Needle-free..
21/1/202522:21EDGAR2Form 144 - Report of proposed sale of securities
21/1/202519:47EDGAR2Form 144 - Report of proposed sale of securities
21/1/202514:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202522:20EDGAR2Form 144 - Report of proposed sale of securities
16/1/202522:15PRNUSBD to Announce Financial Results for its First Quarter of..
15/1/202512:50PRNUSBD Boosts U.S. Manufacturing of Critical Medical Devices
13/1/202512:50PRNUSNew ASCCP Guidelines Include More Precise Method of Cervical..
10/1/202513:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202512:59EDGAR2Form 8-K - Current report
10/1/202512:50PRNUSBD Names Pamela Spikner as Chief Accounting Officer and..
09/1/202512:50PRNUSNew Survey Finds Women Are Skipping Their OB/GYN Exams,..
07/1/202522:19EDGAR2Form 144 - Report of proposed sale of securities
07/1/202522:15PRNUSBD To Host Virtual 2025 Annual Meeting of Shareholders
07/1/202502:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202416:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202422:20EDGAR2Form 144 - Report of proposed sale of securities
19/12/202416:49EDGAR2Form ARS - Annual Report to Security Holders
19/12/202416:39EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
19/12/202416:36EDGAR2Form DEF 14A - Other definitive proxy statements
17/12/202412:50PRNUSBD and Babson Diagnostics Launch Innovative Fingertip Blood..
16/12/202422:32PRNUSBD Resolves Previously Disclosed SEC Investigation
11/12/202402:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/12/202402:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/12/202422:47EDGAR2Form 144 - Report of proposed sale of securities
06/12/202422:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202422:31EDGAR2Form 144 - Report of proposed sale of securities
06/12/202422:31EDGAR2Form 144 - Report of proposed sale of securities
05/12/202422:42EDGAR2Form 144 - Report of proposed sale of securities
05/12/202422:05GLOBEMaravai LifeSciences Appoints R. Andrew Eckert as Chairman..
30/11/202400:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/11/202416:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/11/202416:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/11/202416:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/11/202416:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: Min: Max:
Chiusura: 242,42

La tua Cronologia

NYSE
BDX
Becton Dickinson
LSE
43BF
Anglian. 2027
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci